Can a CLIA clinical lab in the US create an LDT by obtaining a protocol for a test developed as an LDT by another facility outside US? We found this documented in a few references online but fail to understand how would you satisfy FDA's requirement of LDTs as designed, developed and manufactured within a single lab.
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
email@example.com+1 301 770 2920
JoinMy RAPS DashboardLearn More